Samarkan (Plenary) Free Papers
Date
Tue, Apr 10, 2018
Time
13:30 - 15:00
Location
Samarkan (Plenary)
Moderators
  • E. Kon (Rozzano, Italy)
  • C. Lattermann (Lexington, United States of America)
Podium Presentation Clinical Outcome

13.3.1 - RCT Comparing ACI-C Versus AMIC In The Knee (ID 9507)

Presentation Number
13.3.1
Topic
Clinical Outcome
Lecture Time
13:30 - 13:39
Corresponding Author
  • G. Knutsen (Tromsoe, Norway)
Authors
  • G. Knutsen (Tromsoe, Norway)
  • V. Fossum
  • A. Hansen
  • T. Wilsgaard
  • O. Johansen
Disclosure
No Significant Commercial Relationships
Podium Presentation Cartilage /Cell Transplantation

13.3.2 - A Single Stage Arthroscopic Autologous Collagen Induced Chondrogenesis - Five Year Results (ID 9394)

Presentation Number
13.3.2
Topic
Cartilage /Cell Transplantation
Lecture Time
13:39 - 13:48
Corresponding Author
  • A. Shetty (Kent)
Authors
  • R. Vaishya (New Delhi, India)
  • N. Shetty
  • D. Stelzeneder (Vienna, Austria)
  • S. Kim
  • A. Shetty (Kent)
Disclosure
No Significant Commercial Relationships
Podium Presentation Cartilage /Cell Transplantation

13.3.3 - Platelet-Rich Plasma Intra-Articular Knee Injections Vs Viscosupplementation: Long-Term Results Of A RCT (ID 9518)

Presentation Number
13.3.3
Topic
Cartilage /Cell Transplantation
Lecture Time
13:48 - 13:57
Corresponding Author
  • G. Filardo (Bologna, Italy)
Authors
  • G. Filardo (Bologna, Italy)
  • B. Di Matteo (Bologna, Italy)
  • A. Di Martino
  • A. Sessa
  • F. Tentoni (Bologna, Italy)
  • S. Zaffagnini
  • E. Kon (Rozzano, Italy)
Disclosure
No Significant Commercial Relationships
Podium Presentation Osteoarthritis

13.3.4 - A 52 week Randomized, Double-Blind Phase 2 Study Of Intra-Articular, Wnt Pathway Inhibitor (SM04690) For Osteoarthritis (ID 9588)

Presentation Number
13.3.4
Topic
Osteoarthritis
Lecture Time
13:57 - 14:06
Corresponding Author
  • J. Tambiah (San Diego, United States of America)
Authors
  • J. Tambiah (San Diego, United States of America)
  • S. Kennedy (San Diego, United States of America)
  • C. Swearingen
  • I. Simsek
  • A. Gomoll (Boston, United States of America)
  • D. Jones
  • M. Jones
  • J. Bergfeld
Disclosure
A.Gomoll, NuTech, Consultant M.Jones, Samumed, Consultant S.Kennedy, Samumed, Employee,Shareholder I. Simsek, Samumed, Employee, Shareholder C.Swearingen, Samumed, Employee,Shareholder J.Tambiah, Samumed, Employee, Shareholder
Podium Presentation Osteoarthritis

13.3.5 - An Autologous Protein Solution Injection Reduces Knee Osteoarthritis Pain in a Saline-Controlled RCT: 2 Year Outcomes (ID 9663)

Presentation Number
13.3.5
Topic
Osteoarthritis
Lecture Time
14:06 - 14:15
Corresponding Author
  • E. Kon (Rozzano, Italy)
Authors
  • E. Kon (Rozzano, Italy)
  • L. Engebretsen (Oslo, Norway)
  • P. Verdonk (Antwerp, Belgium)
  • S. Nehrer (Krems, Austria)
  • L. Andriolo (Bologna, Italy)
  • G. Filardo (Bologna, Italy)
Disclosure
Funding,BiometZimmer EK,Biomet,Fidia,Finceramica,Cartiheal,presenter SN,ArthroKinetics,ChromaPharma,Biomet,Braincon,research support LE,Arthrex,Biomet,Smith&Nephew,research support PV,ActiveImplants,DePuy,Smith&Nephew,Conmed,consultant GF,Cartiheal,Finceramica,GreenBoneOrtho,presenter
Podium Presentation Clinical Outcome

13.3.6 - Matrix-Induced Autologous Chondrocyte Implantation in the Tibiofemoral Knee Joint: 10-12 Year Follow-Up (ID 10050)

Presentation Number
13.3.6
Topic
Clinical Outcome
Lecture Time
14:15 - 14:24
Corresponding Author
  • J. Ebert (Perth, Australia)
Authors
  • J. Ebert (Perth, Australia)
  • M. Zheng (Crawley, Australia)
  • T. Ackland
  • G. Janes
  • D. Wood (Perth, Australia)
Disclosure
No Significant Commercial Relationships
Podium Presentation Clinical Outcome

13.3.7 - Threshold Values for Preoperative Patient Reported Outcome Scores to Predict Global Function following ACI (ID 10142)

Presentation Number
13.3.7
Topic
Clinical Outcome
Lecture Time
14:24 - 14:33
Corresponding Author
  • J. Howard (Boone, United States of America)
Authors
  • J. Howard (Boone, United States of America)
  • C. Conley - Whale (Lexington, United States of America)
  • C. Jacobs (Lexington, United States of America)
  • C. Lattermann (Lexington, United States of America)
Disclosure
C. Lattermann, Vericel, Consultant C. Lattermann, Cartiheal, Consultant
Podium Presentation Cartilage /Cell Transplantation

13.3.8 - OAT for Treating Femoral Trochlear Cartilage Defects: The Outcomes of 1 Year to 6 Years Follow-up Study. (ID 10170)

Presentation Number
13.3.8
Topic
Cartilage /Cell Transplantation
Lecture Time
14:33 - 14:42
Corresponding Author
  • J. Chen (, United States of America)
Authors
  • Y. Meng (Qingdao, China)
  • J. Chen (, United States of America)
  • Y. Pan
  • H. Feng
  • D. Wang
Disclosure
No Significant Commercial Relationships
Podium Presentation Clinical Outcome

13.3.9 - Clinical Outcome of Patients with Osteoarthritis and Patients without OA, Treated with a Aovel Aragonite-Based Implant (ID 10204)

Presentation Number
13.3.9
Topic
Clinical Outcome
Lecture Time
14:42 - 14:51
Corresponding Author
  • E. Kon (Rozzano, Italy)
Authors
  • N. Altschuler (Kfar Saba, Israel)
  • E. Kon (Rozzano, Italy)
  • P. Verdonk (Antwerp, Belgium)
  • M. Drobnic (Ljubljana, Slovenia)
  • O. Dulic (Novi Sad, Serbia)
  • G. Gavrilovic
  • K. Zaslav (Richmond, United States of America)
  • A. Levy (Millburn, United States of America)
  • M. Patrascu
  • D. Robinson (PetahTikwa, Israel)
Disclosure
E. Kon, Cartiheal, Consultant P. Verdonk, Cartiheal, Consultant G. Gavrilovic, Cartiheal, Consultant O. Dulic, Cartiheal, Consultant D. Robinson, Cartiheal, Consultant M. Drobnic, Cartiheal, Consultant K. Zaslav, Cartiheal, Consultant A. Levy, Cartiheal, Consultant M. Patrascu, Cartiheal, Con
Podium Presentation Cartilage /Cell Transplantation

13.3.10 - Repair of Large Chondral Lesions with Single - Step Chondrocyte and Bone Marrow Cells Co - Transplantation (ID 10224)

Presentation Number
13.3.10
Topic
Cartilage /Cell Transplantation
Lecture Time
14:51 - 15:00
Corresponding Author
  • K. Slynarski (Warszawa, Poland)
Authors
  • K. Slynarski (Warszawa, Poland)
  • L. Lipinski (Lodz, Poland)
Disclosure
No Significant Commercial Relationships